Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Limmatech Biologics AG has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 3 distinct examiners and 3 distinct art units, placing the pending work across separate examination channels.
BARRON, SEAN C is the busiest examiner, with 1 pending matter. Counsel should use examiner-specific and art-unit-specific analysis when preparing responses across the portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BARRON, SEAN C | 1 | 52.7% | +30.4% |
| BRISTOL, LYNN ANNE | 1 | 63.4% | +39.8% |
| GROOMS, TIFFANY NICOLE | 1 | 57.8% | +46.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18404577 | Engineered and Fully-Functional Customized Glycoproteins | BARRON, SEAN C | 36d overdue |
| 18025792 | FAB SIALYLATION OF ANTIBODIES | BRISTOL, LYNN ANNE | — |
| 17791085 | ENGINEERED LEISHMANIA CELLS | GROOMS, TIFFANY NICOLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18404577 | Engineered and Fully-Functional Customized Glycoproteins | BARRON, SEAN C | 36d overdue |
| 18025792 | FAB SIALYLATION OF ANTIBODIES | BRISTOL, LYNN ANNE | — |
| 17791085 | ENGINEERED LEISHMANIA CELLS | GROOMS, TIFFANY NICOLE | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| 1643 | 1 |
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18404577 | Engineered and Fully-Functional Customized Glycoproteins | BARRON, SEAN C | 1653 | §102§103 | Final Rejection | 36d overdue | Pending | Jan 04, 2024 |
| 18025792 | FAB SIALYLATION OF ANTIBODIES | BRISTOL, LYNN ANNE | 1643 | §103§112 | Non-Final OA | — | Pending | Mar 10, 2023 |
| 17791085 | ENGINEERED LEISHMANIA CELLS | GROOMS, TIFFANY NICOLE | 1637 | §102§103 | Final Rejection | — | Pending | Jul 06, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLimmatech Biologics AG has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Sean C Barron has the most, with 1 of Limmatech Biologics AG's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
